Texas researchers say they have perfected a method to deliver cancer treatment directly into tumors, bypassing healthy tissue. The study was done on mice, but human trials could begin soon, said Dr. Michael Andreeff, one author of the study in Wednesday’s issue of the Journal of the National Cancer Institute.